Home › Funds › Versant Venture Management, LLC › LENZ

Versant Venture Management, LLC position in LENZ

Lenz Therapeutics, Inc. · Health Care

Versant Venture Management, LLC reported holding 2,656,888 shares of LENZ (Lenz Therapeutics, Inc.) in its Q3 2026 13F filing — a position valued at US$10.2M, representing 9.35% of its reported portfolio and ranking #5 among its reported holdings. Versant Venture Management, LLC has disclosed LENZ holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)2.66M sh
Reported value held$10.20M
Portfolio Weight9.35%
First reportedQ3 2025
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Versant Venture Management, LLC's LENZ position evolved

Versant Venture Management, LLC first disclosed a stake in LENZ in Q3 2025 at 2,656,888 shares (US$123.8M). Across 5 filings, Versant Venture Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 2,656,888 shares valued at US$10.2M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 2.66M $123.76M New
Q4 2025 2.66M $42.51M Hold
Q1 2026 2.66M $24.31M Hold
Q2 2026 2.66M $15.09M Hold
Q3 2026 2.66M $10.20M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LENZ and 13F data

LENZ (Lenz Therapeutics, Inc.) is a Health Care company. 16 other funds we track also report a position in LENZ — the largest reported positions include Alpha Wave Global, LP (US$13.9M), 72 Investment Holdings, LLC (US$5.8M), Blue Owl Capital Holdings LP (US$3.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LENZ

All LENZ fund holders →

FAQ

How long has Versant Venture Management, LLC held LENZ?

Versant Venture Management, LLC has disclosed LENZ holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Versant Venture Management, LLC's current position in LENZ?

As of Q3 2026, Versant Venture Management, LLC holds 2.66M shares of LENZ (Lenz Therapeutics, Inc.), valued at $10.20M, representing 9.35% of its reported portfolio and ranking #5.

Has Versant Venture Management, LLC been buying or selling LENZ?

In the latest 13F filing (Q3 2026), Versant Venture Management, LLC held unchanged its position in LENZ.

Which other funds hold LENZ?

Other major institutional holders of LENZ include Alpha Wave Global, LP, 72 Investment Holdings, LLC, Blue Owl Capital Holdings LP, among 16 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.